{"id":30,"date":"2012-03-08T20:30:31","date_gmt":"2012-03-08T11:30:31","guid":{"rendered":"http:\/\/urology.dept.med.gunma-u.ac.jp\/?p=30"},"modified":"2012-03-23T17:24:58","modified_gmt":"2012-03-23T08:24:58","slug":"2010announcement","status":"publish","type":"post","link":"https:\/\/urology.dept.med.gunma-u.ac.jp\/?p=30","title":{"rendered":"2010\u5e74\u3000\u5b66\u4f1a\u767a\u8868"},"content":{"rendered":"
    \n
  1. Sekine Y, Suzuki K and Remaley A\uff1aHDL and sphingosine-1-phosphate activate signal transducer and activator of transcription 3 in prostate cancer DU145 cells via ERK1\/2 and S1P receptors. AACR 101st Annual Meeting 2010, Apr. 21, 2010, Washington,DC, USA.<\/li>\n
  2. Ito K, Miyakubo M, Yamamoto T and Suzuki K\uff1aDiagnostic significance of [-2]proPSA and volume adjusted PSA-related indices in Japanese men with total PSA in the 2.0 to 10.0 ng\/mL range. The 105th Annual Meeting of American Urological Association, Jun. 1, 2010, San Francisco, USA.<\/li>\n
  3. Ito K\uff1aControversy over prostate- specific antigen screening has shifted from mortality to overtreatment issues. The 105th Annual Meeting of American Urological Association, Jun. 1, 2010, San Francisco, USA.<\/li>\n
  4. Koike H, Morikawa Y, Nitta T, Furuya Y, Sekine Y, Matsui H and Suzuki K\uff1aStatin inhibits the proliferation of human prenal cancer cells via down-regulation of the survivin through IGF-1 signaling. The 105th Annual Meeting of American Urological Association, May. 30, 2010, San Francisco, USA.<\/li>\n
  5. Shibata Y, Arai S, Kashiwagi B, Ito K, Honma S and Suzuki K\uff1aDetection of membrane androgen-binding site in living rat prostate and evaluation of its role in prostate blood flow regulation. The 105th Annual Meeting of American Urological Association, Jun. 1, 2010, San Francisco, USA.<\/li>\n
  6. Sekine Y, Furuya Y, Koike H, Suzuki K and Remaley A\uff1aHigh density lipoprotein induces proliferation and migration of human prostate androgen independent cancer cells via ATP-binding cassette transporter A1 by A cholesterol-independent mechanism. The 105th Annual Meeting of American Urological Association, May. 30, 2012, San Francisco, USA.<\/li>\n
  7. Ito K\uff1aRecent development of prostate cancer: Recent up-date on screening for prostatecCancer. The 9th International Conference of the Asian Clinical Oncology Society (ACOS) Symposium (S11), Aug. 27, 2010, Gifu.<\/li>\n
  8. Arai S, Miyashiro Y, Shibata Y, Kashiwagi B, Tomaru Y, Kobayashi M, Honma S and Suzuki K\uff1aNew quantification method for estradiol in the prostatic tissues of benign prostatic hyperplasia using liquid chromatography-tandem mass spectrometry. The 25th Annual European Association of Urology Congress, Apr. 18, 2010, Barcelona, Spain.<\/li>\n
  9. Ito K, Miyakubo M, Yamamoto T, Suzuki K, Kobayashi M, Tomaru Y, Tanaka H and Yamanaka H\uff1aJapanese Prospective Cohort Study of Screening for Prostate Cancer (JPSPC): Analyses on compliance, contamination and mortality until 2008 (Gunma section). The 25th Annual European Association of Urology Congress, Apr. 19, 2010, Barcelona, Spain.<\/li>\n
  10. Koike H, Matsui H, Shibata Y, Ito K and Suzuki K\uff1aChlormadinone acetate is effective for hot flush in androgen deprivation therapy. The 25th Annual European Association of Urology Congress, Apr. 17, 2010, Barcelona, Spain.<\/li>\n
  11. Koike H, Sekine Y, Furuya Y, Morikawa Y, Matsui H, Shibata Y and Suzuki K\uff1aStatin inhibits the proliferation of human prostate cancer cells via down-regulation of the survivin. The 25th Annual European Association of Urology Congress, Apr. 19, 2010, Barcelona, Spain.<\/li>\n
  12. Shibata Y, Arai S, Koike H, Ito K and Suzuki K\uff1aUsefulness of real-time transrectal ultrasound navigation for shortening the learning curve when mastering the holmium laser enucleation technique for symptomatic benign prostatic hyperplasia. The 25th Annual European Association of Urology Congress, Apr. 19, 2010, Barcelona, Spain.<\/li>\n
  13. Ito K, Miyakubo M, Suzuki K, Kobayashi M, Takezawa Y, Kosaku N, Yamamoto T and Tomaru Y\uff1aJapanese Prospective Cohort Study of Screening for Prostate Cancer (JPSPC): analyses on compliance and contamination until 2008 (Gunma section). The 3rd World Congress on Controversies in Urology (CURy), Feb. 27, 2010, Athens, Greece.<\/li>\n
  14. Arai S, Miyashiro Y, Shibata Y, Tomaru Y, Kobayashi M, Honma S and Suzuki K\uff1aEffect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues. The 6th International Symposium on Hormonal Carcinogenesis in Japan, Sep. 14, 2010, Urayasu.<\/li>\n
  15. \u67f4\u7530\u5eb7\u535a\uff1a\u524d\u7acb\u817a\u7d44\u7e54\u5185\u30db\u30eb\u30e2\u30f3\u5b9a\u91cf\u6cd5\u306e\u9032\u6b69\u3068\u610f\u7fa9. \u7b2c\uff13\u56de\u524d\u7acb\u817a\u751f\u7269\u5b66\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u4f0a\u52e2\u5fd7\u64692010, 2010\u5e746\u670818\u65e5, \u9ce5\u7fbd\u5e02.<\/li>\n
  16. \u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u306e\u6700\u65b0\u60c5\u5831. \u5e73\u621021\u5e74\u5ea6\u7b2c\uff12\u56de\u3000\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u8b1b\u7fd2\u4f1a, 2010\u5e742\u67084\u65e5, \u798f\u5ca1.<\/li>\n
  17. \u4f0a\u85e4\u4e00\u4eba\uff1a\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u306e\u65b0\u305f\u306a\u5c55\u958b. \u5e73\u621022\u5e74\u5ea6\u7b2c1\u56de\u3000\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u8b1b\u7fd2\u4f1a, 2010\u5e7410\u67085\u65e5, \u798f\u5ca1.<\/li>\n
  18. \u5c0f\u6c60\u79c0\u548c\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u5ca1\u672c\u4e98\u5e73\u3001\u91ce\u6751\u660c\u53f2\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u677e\u4e95\u3000\u535a\u3001\u4e2d\u91cc\u6674\u6a39\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u518d\u71c3\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b\u30c9\u30bb\u30bf\u30ad\u30bb\u30eb\u7642\u6cd5\u306e\u691c\u8a0e. \u7b2c26\u56de\u524d\u7acb\u817a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, 2010\u5e7412\u670812\u65e5, \u6771\u4eac.<\/li>\n
  19. \u4f0a\u85e4\u4e00\u4eba\u3001\u7b67\u3000\u5584\u884c\u3001\u5185\u85e4\u8aa0\u4e8c\u3001\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u4f5c\u6210\u59d4\u54e1\u4f1a\u30e1\u30f3\u30d0\u30fc\uff1aJUA\u6ccc\u5c3f\u5668\u304c\u3093\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\uff1a\u524d\u7acb\u817a\u764c\u691c\u8a3a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3. \u7b2c48\u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a \u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f310, 2010\u5e7410\u670828\u65e5, \u4eac\u90fd.<\/li>\n
  20. \u4f0a\u85e4\u4e00\u4eba\u3001\u8d64\u5009\u529f\u4e00\u90ce\u3001\u5c71\u672c\u3000\u5de7\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u7530\u4e2d\u5553\u5e79\u3001\u5cf6\u5d0e\u3000\u6df3\u3001\u5c71\u4e2d\u82f1\u58fd\u3001\u524d\u7acb\u817a\u304c\u3093\u64b2\u6ec5\u63a8\u9032\u59d4\u54e1\u4f1a\u30e1\u30f3\u30d0\u30fc\uff1a2008\u5e74\u5ea6\u306e\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u75be\u60a3\u7d99\u7d9a\u7814\u7a76\u30fb\u5bfe\u7167\u7814\u7a76\u306e\u691c\u8a3a\u7d50\u679c. \u7b2c48\u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2010\u5e7410\u670828\u65e5, \u4eac\u90fd.<\/li>\n
  21. \u5c0f\u6c60\u79c0\u548c\u3001\u65b0\u7530\u8cb4\u58eb\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u677e\u4e95\u3000\u535a\u3001\u9234\u6728\u548c\u6d69\uff1a\u30b9\u30bf\u30c1\u30f3\u306esurvivin\u6291\u5236\u306b\u3088\u308b\u814e\u764c\u7d30\u80de\u5897\u6b96\u6291\u5236\u52b9\u679c. \u7b2c48\u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, 2010\u5e7410\u670829\u65e5, \u4eac\u90fd.<\/li>\n
  22. \u4f0a\u85e4\u4e00\u4eba\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u9234\u6728\u548c\u6d69\u3001\u7530\u4e2d\u5553\u5e79\u3001\u5c71\u4e2d\u82f1\u58fd\uff1aJapanese Prospective Cohort Study of Screening for Prostate Cancer(JPSPC):post ERSPC era\u306b\u304a\u3051\u308b\u7814\u7a76\u306e\u4f4d\u7f6e\u3065\u3051\u3068\u81e8\u5e8a\u7684\u610f\u7fa9. \u7b2c19\u56de\u65e5\u672c\u814e\u6ccc\u5c3f\u5668\u75be\u60a3\u4e88\u9632\u533b\u5b66\u7814\u7a76\u4f1a \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u2161, 2010\u5e747\u67089\u65e5, \u5343\u8449.<\/li>\n
  23. \u65b0\u4e95\u8aa0\u4e8c\u3001\u5bae\u4ee3\u597d\u901a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u67cf\u6728\u6587\u8535\u3001\u767b\u4e38\u884c\u96c4\u3001\u5c0f\u6797\u5e79\u7537\u3001\u672c\u9593\u8aa0\u6b21\u90ce\u3001\u9234\u6728\u548c\u6d69\uff1a\u6db2\u4f53\u30af\u30ed\u30de\u30c8\u30b0\u30e9\u30d5\u30a3\u30fc\u30fb\u30bf\u30f3\u30c7\u30e0\u8cea\u91cf\u5206\u6790\u8a08\u306b\u3088\u308b\u524d\u7acb\u817a\u7d44\u7e54\u5185\u30a8\u30b9\u30c8\u30e9\u30b8\u30aa\u30fc\u30eb\u5b9a\u91cf\u6cd5. \u7b2c98\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 2010\u5e744\u670829\u65e5, \u76db\u5ca1\u5e02.<\/li>\n
  24. \u5c0f\u6c60\u79c0\u548c\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u65b0\u4e95\u8aa0\u4e8c\u3001\u677e\u4e95\u3000\u535a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u9234\u6728\u548c\u6d69\uff1a\u524d\u7acb\u817a\u764c\u306b\u304a\u3051\u308b\u6d3b\u6027\u578b\u30d3\u30bf\u30df\u30f3D3(1\u03b1, 25(OH)2D3)\u306e\u52b9\u679c\u3068survivin\u306e\u95a2\u4e0e. \u7b2c98\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 2010\u5e744\u670827\u65e5, \u76db\u5ca1\u5e02.<\/li>\n
  25. \u67f4\u7530\u5eb7\u535a\u3001\u9234\u6728\u548c\u6d69\u3001\u7aaa\u7530\u5409\u4fe1\u3001\u4e09\u597d\u5eb7\u79c0\u3001\u585a\u672c\u6cf0\u53f8\u3001\u5e02\u5ddd\u667a\u5f66\u3001\u4e26\u6728\u5e79\u592b\u3001\u6749\u6751\u82b3\u6a39\u3001\u5965\u5c71\u660e\u5f66\u3001\u91d1\u6b66\u3000\u6d0b\uff1a\u7d44\u7e54\u5185\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u6fc3\u5ea6\u306b\u3088\u308b\u524d\u7acb\u817a\u764c\u518d\u71c3\u4e88\u6e2c\uff1a\u7d44\u7e54\u5185\u30a2\u30f3\u30c9\u30ed\u30b2\u30f3\u6fc3\u5ea6\u306b\u3088\u308b\u524d\u7acb\u817a\u764c\u518d\u71c3\u4e88\u6e2c. \u7b2c98\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 2010\u5e744\u670828\u65e5, \u76db\u5ca1\u5e02.<\/li>\n
  26. \u67f4\u7530\u5eb7\u535a\u3001\u9234\u6728\u548c\u6d69\u3001\u5e73\u5c3e\u4f73\u5f66\u3001\u85e4\u672c\u6e05\u79c0\u3001\u5927\u6a4b\u9756\u96c4\u3001\u5c0f\u5ddd\u826f\u96c4\u3001\u51a8\u58eb\u5e78\u8535\u3001\u4e03\u6761\u6b66\u5fd7\u3001\u690d\u6751\u5929\u53d7\u3001\u8fbb\u3000\u79c0\u61b2\u3001\u6734\u3000\u82f1\u54f2\uff1a\u9162\u9178\u30af\u30ed\u30eb\u30de\u30b8\u30ce\u30f3\u306b\u3088\u308b\u524d\u7acb\u817a\u80a5\u5927\u75c7\u60a3\u8005\u306e\u8840\u4e2dPSA\u5024\u306b\u4e0e\u3048\u308b\u5f71\u97ff. \u7b2c98\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 2010\u5e744\u670829\u65e5, \u76db\u5ca1\u5e02.<\/li>\n
  27. \u53e4\u8c37\u6d0b\u4ecb\u3001\u9ed2\u5ddd\u516c\u5e73\u3001\u5ca1\u672c\u4e98\u5e73\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u7267\u91ce\u6b66\u6717\uff1a\u524d\u7acb\u817a\u764c\u8a3a\u7642\u306b\u304a\u3051\u308b\u751f\u691c\u8fc5\u901f\u8a3a\u65ad+\u9664\u777e\u8853. \u7b2c98\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 2010\u5e744\u670828\u65e5, \u76db\u5ca1\u5e02.<\/li>\n
  28. \u677e\u4e95\u3000\u535a\u3001\u798f\u9593\u88d5\u4e8c\u3001\u6ff1\u91ce\u9054\u4e5f\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u5927\u7af9\u4f38\u660e\u3001\u4e2d\u7530\u8aa0\u53f8\u3001\u9234\u6728\u548c\u6d69\uff1a\u5bb6\u65cf\u6027\u524d\u7acb\u817a\u764c\u8cac\u4efb\u907a\u4f1d\u5b50\u306e\u5019\uff1afarnesyldiphosphate farnesyltransferase 1\uff08FDFT 1\uff09\u907a\u4f1d\u5b50\u591a\u578b\u3068\u6a5f\u80fd\u89e3\u6790\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e. \u7b2c98\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a, 2010\u5e744\u670827\u65e5, \u76db\u5ca1\u5e02.<\/li>\n
  29. \u4f0a\u85e4\u4e00\u4eba\uff1a\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u524d\u7acb\u817a\u304c\u3093\u691c\u8a3a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f32010\u5e74\u5897\u88dc\u7248\u306e\u6982\u8981\u3068\u5c06\u6765\u306e\u65b9\u5411\u6027. \u7b2c57\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u6771\u90e8\u7dcf\u4f1a\u3000\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff15, 2010\u5e749\u670817\u65e5, \u5b87\u90fd\u5bae.<\/li>\n
  30. \u5927\u6728\u3000\u4eae\u3001\u5869\u91ce\u662d\u5f66\u3001\u5c0f\u6797\u5927\u5fd7\u6717\u3001\u753a\u7530\u660c\u5df3\u3001\u7267\u91ce\u6b66\u96c4\u3001\u67f4\u5c71\u52dd\u592a\u90ce\uff1a\u67f4\u82d3\u6e6f\u304c\u8457\u52b9\u3057\u305f\u5f8c\u8179\u819c\u7dda\u7dad\u75c7\u306e\u4e00\u4f8b. \u7b2c54\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2010\u5e742\u67086\u65e5, \u524d\u6a4b.<\/li>\n
  31. \u53e4\u8c37\u6d0b\u4ecb\u3001\u9ed2\u5ddd\u516c\u5e73\u3001\u6839\u5cb8\u3000\u5e7e\u3001\u4f50\u85e4\u6b63\u901a\u3001\u5c71\u7530\u9054\u4e5f\u3001\u5742\u7530\u4e00\u5b8f\u3001\u5c0f\u5ddd\u3000\u6643\u3001\u753a\u4e26\u7766\u751f\u3001\u7267\u91ce\u6b66\u6717\uff1a\u5f8c\u8179\u819cMFH(malignant fibrous histiocytoma)\u306e\u4e00\u4f8b. \u7b2c54\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2010\u5e742\u67086\u65e5, \u524d\u6a4b.<\/li>\n
  32. \u65b0\u4e95\u8aa0\u4e8c\u3001\u67f4\u7530\u5eb7\u535a\u3001\u51a8\u7530\u5065\u4ecb\u3001\u6a2a\u5c71\u7531\u5c31\u3001\u5ee3\u91ce\u6b63\u6cd5\u3001\u7267\u91ce\u6b66\u6717\u3001\u6751\u677e\u548c\u9053\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u5ca1\u672c\u4e98\u5e73\u3001\u91ce\u6751\u660c\u53f2\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u5f53\u9662\u306b\u304a\u3051\u308b\u5927\u304d\u306a\u524d\u7acb\u817a\u80a5\u5927\u75c7\u306b\u5bfe\u3059\u308bHoLEP\u306e\u6cbb\u7642\u6210\u7e3e\u306e\u691c\u8a0e. \u7b2c54\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2010\u5e742\u67086\u65e5, \u524d\u6a4b.<\/li>\n
  33. \u65b0\u7530\u8cb4\u58eb\u3001\u6ff1\u91ce\u9054\u4e5f\u3001\u5ddd\u53e3\u62d3\u4e5f\uff1a\u771f\u83cc\u6027\u814e\u76c2\u814e\u708e\u306e\uff11\u4f8b. \u7b2c54\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2010\u5e742\u67086\u65e5, \u524d\u6a4b.<\/li>\n
  34. \u65b0\u4e95\u8aa0\u4e8c\u3001\u84ee\u898b\u3000\u52dd\u3001\u6e05\u6c34\u4fe1\u660e\u3001\u98ef\u5cf6\u7f8e\u7802\uff1a\u7cbe\u5de3\u30ab\u30eb\u30c1\u30ce\u30a4\u30c9\u816b\u760d\u306e\uff11\u4f8b. \u7b2c55\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2010\u5e746\u670819\u65e5, \u524d\u6a4b.<\/li>\n
  35. \u51a8\u7530\u5065\u4ecb\u3001\u5869\u91ce\u662d\u5f66\u3001\u5c0f\u6797\u5927\u5fd7\u6717\u3001\u753a\u7530\u660c\u5df3\u3001\u7267\u91ce\u6b66\u96c4\u3001\u67f4\u5c71\u52dd\u592a\u90ce\u3001\u672c\u9593\u3000\u5b66\uff1a\u814e\u7d30\u80de\u764c\u8853\u5f8c\uff13\u5e74\u76ee\u306b\u81b5\u8ee2\u79fb\u3092\u304d\u305f\u3057\u305f\u4e00\u4f8b. \u7b2c55\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2010\u5e746\u670819\u65e5, \u524d\u6a4b.<\/li>\n
  36. \u5bae\u6fa4\u6176\u884c\u3001\u4e0a\u4e95\u5d07\u667a\u3001\u767b\u4e38\u884c\u96c4\uff1a\u30a4\u30f3\u30bf\u30fc\u30d5\u30a7\u30ed\u30f3\u03b1\u6295\u4e0e\u4e2d\u306b\u5897\u60aa\u50be\u5411\u3092\u8a8d\u3081\u305f\u304c\u4f11\u6b62\u5f8c\u306b\u81ea\u7136\u6d88\u9000\u3092\u8a8d\u3081\u305f\u814e\u7d30\u80de\u764c\u306e\uff11\u4f8b. \u7b2c55\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2010\u5e746\u670819\u65e5, \u524d\u6a4b.<\/li>\n
  37. \u6751\u677e\u548c\u9053\u3001\u9ed2\u5ddd\u516c\u5e73\u3001\u5c71\u7530\u9054\u4e5f\u3001\u6839\u5cb8\u3000\u5e7e\u3001\u677e\u5c3e\u5f25\u679d\u3001\u9593\u4ec1\u7530\u5b88\uff1a\u30d5\u30eb\u30cb\u30a8\u58ca\u75bd\u304c\u7591\u308f\u308c\u305f\u5c3f\u9589\u75c7\u4f8b. \u7b2c55\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2010\u5e746\u670819\u65e5, \u524d\u6a4b.<\/li>\n
  38. \u5742\u672c\u4eae\u4e00\u90ce\u3001\u5965\u6728\u5b8f\u5ef6\u3001\u5ca1\u5d0e\u3000\u6d69\u3001\u4e2d\u6751\u654f\u4e4b\uff1aLHRH\u30a2\u30ca\u30ed\u30b0\u88fd\u5264\u5909\u66f4\u306b\u3088\u308aPSA\u4f4e\u4e0b\u3092\u3082\u305f\u3089\u3057\u305f\uff11\u4f8b. \u7b2c55\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2010\u5e746\u670819\u65e5, \u524d\u6a4b.<\/li>\n
  39. \u91ce\u6751\u660c\u53f2\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\u3001\u51a8\u7530\u5065\u4ecb\u3001\u6751\u677e\u548c\u9053\u3001\u7267\u91ce\u6b66\u6717\u3001\u5c0f\u6797\u5e79\u7537\uff1a\u53f3\u5de8\u5927\u6c34\u814e\u75c7\u306b\u5bfe\u3057\u3066\u5f8c\u8179\u8154\u93e1\u4e0b\u53f3\u814e\u6458\u9664\u8853\u3092\u65bd\u884c\u3057\u305f\u4e00\u4f8b. \u7b2c55\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a, 2010\u5e746\u670819\u65e5, \u524d\u6a4b.<\/li>\n
  40. \u5927\u6728\u3000\u4eae\u3001\u5927\u585a\u4fdd\u5b8f\u3001\u4e2d\u91ce\u52dd\u4e5f\u3001\u9234\u6728\u5b5d\u61b2\u3001\u9ad8\u6a4b\u6ea5\u670b\u3001\u524d\u7530\u7bc0\u592b\uff1a\u5de6\u814e\u9759\u8108\u816b\u760d\u585e\u6813\u3092\u4f34\u3046\u814e\u8840\u7ba1\u7b4b\u8102\u80aa\u816b\u306e\u4e00\u4f8b. \u7b2c\uff19\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u6803\u6728\u30fb\u7fa4\u99ac\u5408\u540c\u5730\u65b9\u4f1a\uff08\u7b2c56\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a\uff09, 2010\u5e7411\u670814\u65e5, \u3055\u3044\u305f\u307e\u5e02.<\/li>\n
  41. \u65b0\u4e95\u8aa0\u4e8c\u3001\u84ee\u898b\u3000\u52dd\u3001\u6e05\u6c34\u4fe1\u660e\uff1a\u5f53\u9662\u306b\u304a\u3051\u308b\u7cbe\u5de3\u816b\u760d\u306e\u81e8\u5e8a\u7684\u691c\u8a0e. \u7b2c\uff19\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u6803\u6728\u30fb\u7fa4\u99ac\u5408\u540c\u5730\u65b9\u4f1a\uff08\u7b2c56\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a\uff09, 2010\u5e7411\u670814\u65e5, \u3055\u3044\u305f\u307e\u5e02.<\/li>\n
  42. \u6751\u677e\u548c\u9053\u3001\u60a6\u6c38\u3000\u5fb9\u3001\u9ed2\u5ddd\u516c\u5e73\uff1a\u8d85\u9ad8\u9f62\u8005\u5de8\u5927\u8180\u80f1\u764c2\u4f8b. \u7b2c\uff19\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u6803\u6728\u30fb\u7fa4\u99ac\u5408\u540c\u5730\u65b9\u4f1a\uff08\u7b2c56\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a\uff09, 2010\u5e7411\u670814\u65e5, \u3055\u3044\u305f\u307e\u5e02.<\/li>\n
  43. \u5742\u672c\u4eae\u4e00\u90ce\u3001\u5965\u6728\u5b8f\u5ef6\u3001\u5ca1\u5d0e\u3000\u6d69\u3001\u4e2d\u6751\u654f\u4e4b\uff1a\u814e\u304a\u3088\u3073\u4e0a\u90e8\u5c3f\u7ba1\u7d50\u77f3\u3078\u306eTUL\u306e\u7d4c\u9a13. \u7b2c\uff19\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u6803\u6728\u30fb\u7fa4\u99ac\u5408\u540c\u5730\u65b9\u4f1a\uff08\u7b2c56\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a\uff09, 2010\u5e7411\u670814\u65e5, \u3055\u3044\u305f\u307e\u5e02.<\/li>\n
  44. \u52a0\u85e4\u6625\u96c4\u3001\u67f4\u7530\u5eb7\u535a\u3001\u5bae\u5c3e\u6b66\u58eb\u3001\u6817\u539f\u8070\u592a\u3001\u4e2d\u5c71\u7d18\u53f2\u3001\u5468\u6771\u5b5d\u6d69\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u5ca1\u672c\u4e98\u5e73\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u91ce\u6751\u660c\u53f2\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\uff1a\u8edf\u6027\u814e\u76c2\u5c3f\u7ba1\u30d3\u30c7\u30aa\u30b9\u30b3\u30fc\u30d7URF-V\u3092\u7528\u3044\u305f\u814e\u7d50\u77f3\u7834\u7815\u8853(f-TUL)\u306e\u7d4c\u9a13. \u7b2c\uff19\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u6803\u6728\u30fb\u7fa4\u99ac\u5408\u540c\u5730\u65b9\u4f1a\uff08\u7b2c56\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a\uff09, 2010\u5e7411\u670814\u65e5, \u3055\u3044\u305f\u307e\u5e02.<\/li>\n
  45. \u91ce\u6751\u660c\u53f2\u3001\u6817\u539f\u8070\u592a\u3001\u4e2d\u5c71\u7d18\u53f2\u3001\u5bae\u5c3e\u6b66\u58eb\u3001\u52a0\u85e4\u6625\u96c4\u3001\u5468\u6771\u5b5d\u6d69\u3001\u53e4\u8c37\u6d0b\u4ecb\u3001\u5bae\u4e45\u4fdd\u771f\u610f\u3001\u68ee\u5ddd\u6cf0\u5982\u3001\u5ca1\u672c\u4e98\u5e73\u3001\u95a2\u6839\u82b3\u5cb3\u3001\u5c0f\u6c60\u79c0\u548c\u3001\u677e\u4e95\u3000\u535a\u3001\u67f4\u7530\u5eb7\u535a\u3001\u7fbd\u9ce5\u57fa\u660e\u3001\u4f0a\u85e4\u4e00\u4eba\u3001\u9234\u6728\u548c\u6d69\u3001\u5c0f\u6797\u5e79\u7537\uff1a\u8910\u8272\u7d30\u80de\u816b\u306b\u5bfe\u3059\u308b\u8179\u8154\u93e1\u4e0b\u624b\u8853\u306e\u691c\u8a0e. \u7b2c\uff19\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u6803\u6728\u30fb\u7fa4\u99ac\u5408\u540c\u5730\u65b9\u4f1a\uff08\u7b2c56\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7fa4\u99ac\u5730\u65b9\u4f1a\uff09, 2010\u5e7411\u670814\u65e5, \u3055\u3044\u305f\u307e\u5e02.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Sekine Y, Suzuki K and Remaley A\uff1aHDL and sphingosine-1-phosphate activate signal transducer and activator of t […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-30","post","type-post","status-publish","format-standard","hentry","category-society"],"_links":{"self":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/30","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30"}],"version-history":[{"count":0,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/posts\/30\/revisions"}],"wp:attachment":[{"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urology.dept.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}